4.5 Letter

Response to tozinameran (BNT162b2) booster in twice-vaccinated kidney transplant and maintenance dialysis patients

Journal

JOURNAL OF NEPHROLOGY
Volume 35, Issue 3, Pages 761-763

Publisher

SPRINGER HEIDELBERG
DOI: 10.1007/s40620-021-01235-3

Keywords

COVID-19; Viral infections; Booster; Vaccines; End stage renal disease; Kidney transplantation; Hemodialysis; Peritoneal dialysis

Funding

  1. Ministry of Health of the State of Israel

Ask authors/readers for more resources

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.5
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available